We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients.
- Authors
Aries, James A.; Davies, Jeffrey K.; Auer, Rebecca L.; Hallam, Simon L.; Montoto, Silvia; Smith, Matthew; Sevillano, Belen; Foggo, Vanessa; Wrench, Bela; Zegocki, Krzysztof; Agrawal, Samir; Le Dieu, Rifca; Truelove, Edward; Erblich, Thomas; Araf, Shamzah; Okosun, Jessica; Oakervee, Heather; Cavenagh, Jamie D.; Gribben, John G.; Riches, John C.
- Abstract
Keywords: coronavirus; lymphomas; leukaemia; myeloma; virology EN coronavirus lymphomas leukaemia myeloma virology e64 e67 4 07/20/20 20200715 NES 200715 Since being identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic with over 4 million cases and more than 270 000 deaths.1 Following the first reported cases in the United Kingdom (UK) in late January 2020, numbers have continued to rise, with 223 060 cases and 32 065 deaths reported as of May 11, 2020.2 Initial reports from China have indicated that COVID-19 has an overall mortality rate of 1-4%. Of 12 patients who had multiple myeloma, five patients had chronic lymphocytic leukaemia, four patients had each of diffuse large B cell lymphoma and acute lymphoblastic leukaemia, three patients had follicular lymphoma, two patients had acute myeloid leukaemia, along with one patient with each of aplastic leukaemia, myelofibrosis, monoclonal gammopathy of undetermined significance, mantle cell lymphoma and myelodysplastic syndrome.
- Subjects
COVID-19; MONOCLONAL gammopathies; COVID-19 pandemic; ACUTE myeloid leukemia; LYMPHOCYTIC leukemia; ACUTE leukemia
- Publication
British Journal of Haematology, 2020, Vol 190, Issue 2, pe64
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.16852